VERA: Vera Therapeutics, Inc. Book Value per Share
Vera Therapeutics, Inc. (VERA) possesses significant market influence due to the inelastic demand for its unique nephropathy treatment, with the indicator standing at 5.67. Breakthrough developments for combating autoimmune kidney pathologies are currently undergoing clinical trials. The available price action reflects the dynamics of a company whose operations rely on establishing new nephrology standards by targeting the root causes of diseases.
Summary analytical data breakdowns for veratx.com (VERA)
- current quotes and average value forecast:
- market capitalization information:
- business book valuation details:
- debt level and financial liquidity data:
Total Debt to Capital Vera Therapeutics, Inc.|VERA - Long-Term Debt to Capital|Short-Term Debt to Equity Vera Therapeutics|VERA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Vera Therapeutics, Inc.|VERA - Company Long-Term Liabilities|Company Short-Term Debts Vera Therapeutics|Quick Liquidity Indicator veratx.com
- earnings and multiples data:
General company analysis:VERA - Vera Pharma
Vera Therapeutics, Inc. (VERA) utilizes an asset-light model by outsourcing drug production to third-party contractors. The book value per share, equal to 5.67, reflects the difference between all company assets and liabilities divided by the number of shares. This metric determines the actual value of net assets available to shareholders upon business liquidation. Investors decouple fundamental stability from market volatility through equity analysis. The historical trend of the book value per share confirms the enterprise's long-term solvency.
Competitor analysis
ARGX - Net Assets per Single Share|Accounting Value of a Share BNTX (BioNTech Pharma)|ABVX: Book Value per Share|admabiologics.com (ADMA) - Book Value per Share|Net Assets per Single Share Protagonist|Immunovant Inc - Share Book Value|Book Value per Share KNSA|GRFS (Grifols Biemat) - Accounting Value of a Share|Book Value per Share ADPT (Adaptive Biotechnologies)|Book Value per Share celldex.com CLDX|AUPH - Net Assets per Single Share|Accounting Value of a Share BCRX (BioCryst Pharmaceuticals, Inc.)|Dianthus Pharma (DNTH) - Net Assets per Single Share|Accounting Value per Share Pharvaris Pharma|ABCL (AbCellera Biologics Inc) - Book Value per Share|Book Value per Share tourmalinebio.com|Accounting Value per Share PGEN (Precigen)|PHAR (Pharming Group NV) - Accounting Value of a Share|Book Value per Share NKTR (Nektar)|Net Assets per Share Upstream Pharma (UPB)|ZBIO - Net Assets per Single Share|immunome.com (IMNM) - Accounting Value per Share|Gossamer Bio (GOSS) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|Accounting Value per Share SEPN|Book Value per Share Pieris Corp|Net Assets per Single Share Savara Inc. (SVRA)|rigel.com - Equity per Share|Book Value per Share ANAB (AnaptysBio)|Astria Therapeutics Inc (ATXS) - Net Asset Value per Share|ENGN: Accounting Value per Share|RAPT: Net Assets per Single Share|JBIO: Book Value per Share|Net Asset Value per Share aclaristx.com (ACRS)|Net Assets per Single Share Kyverna Therapeutics, Inc.|TLSA: Accounting Value of a Share|Book Value per Share CABA|Book Value per Share Ventyx Biosciences, Inc (VTYX)|Theratechnologies Inc. - Accounting Value per Share|Accounting Value of a Share AVTX|ELDN: Accounting Value per Share|Agenus, Inc. - Book Price of a Share|CLYM: Book Value per Share|Zura Bio Ltd - Accounting Value of a Share|ATYR (aTyr Pharma, Inc.) - Book Value per Share|Net Asset Value per Share Adagene Corp ADAG|Net Assets per Single Share ImageneBio Inc (IMA)|STTK (shattucklabs.com) - Accounting Value of a Share|Book Value per Share EQ (Equillium)|Book Value per Share Connect Biopharma Holdings CNTB|IMUX - Net Assets per Single Share|Share Book Value ATRA|IFRX: Book Value per Share|Net Asset Value per Share X4 Pharmaceuticals Inc. (XFOR)|Accounting Value per Share ACET|Book Value per Share Celularity Corp|Accounting Value per Share INMB (INmune Bio, Inc.)|Book Price of a Share BRNS|Book Value per Share KZR (Kezar Life Sciences, Inc.)|Net Assets per Share SAB Biotherapeutics Inc. (SABS)|Akari Therapeutics plc - Book Value per Share|Enlivex Therapeutics (ENLV) - Accounting Value per Share|q32bio.com (QTTB) - Net Assets per Single Share|GOVX - Net Assets per Share|Accounting Value per Share EDSA|IBIO: Accounting Value of a Share|Book Value per Share CARM|Net Assets per Share XTL Bio|Net Assets per Single Share Bolt Biotherapeutics, Inc. BOLT|HCWB: Equity per Share|Aptevo - Book Value per Share|AIM ImmunoTech, Inc. (AIM) - Accounting Value per Share|ADTX (aditxt.com) - Accounting Value per Share|GRI - Net Assets per Share|Accounting Value per Share XRTX|Net Assets per Single Share HIND|Book Value per Share REVB|INDP - Net Asset Value per Share|Net Assets per Single Share Scinai SCNI|Accounting Value of a Share CALI|Affimed Therapeutics - Book Value per Share|ALLK - Book Value per Share|hookipapharma.com (HOOK) - Net Assets per Single Share|Share Book Value IGMS (IGM Biosciences)|ITOS (iTeos) - Book Value per Share|OCEA: Accounting Value of a Share|Book Value per Share TCBP|Book Value per Share thirdharmonicbio.com (THRD)